Checotah Pharmacy | |
1002 W Gentry Ave, Ste B, Checotah, Oklahoma 74426 | |
(918) 473-3838 |
Name | Checotah Pharmacy |
---|---|
Organization Name | Native Frontier Enterprises |
Location | 1002 W Gentry Ave, Ste B, Checotah, Oklahoma 74426 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (918) 473-3838 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Endo Pharmaceuticals (Nasdaq: ENDP) announced today the completion of its acquisition of Qualitest Pharmaceuticals. Endo announced Sept. 28 that it entered into a definitive agreement to acquire Qualitest Pharmaceuticals, a leading, privately held generics company in the U.S., for approximately $1.2 billion in cash.
RegeneRx Biopharmaceuticals, Inc. announced today that the Company has been notified that two cardiac-related patents will be allowed in Australia and Mexico.
Cancer Genetics, Inc., a leader in oncology-focused personalized medicine, has launched a proprietary urogenital cancer array, UroGenRA, intended for kidney cancer diagnosis and subtyping in its own laboratory.
NYU Langone Medical Center has been awarded more than $30 million in research grants from the National Institute of Health (NIH) for 86 research projects being conducted at NYU School of Medicine across a broad range of basic science and clinical departments.
› Verified 5 days ago
NPI Number | 1043492861 |
Organization Name | STIGLER HEALTH AND WELLNESS CENTER INC |
Doing Business As | CHECOTAH PHARMACY |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 1002 W Gentry Ave Ste B, Checotah, OK 74426 |
Phone Number | 918-473-3838 |
News Archive
Endo Pharmaceuticals (Nasdaq: ENDP) announced today the completion of its acquisition of Qualitest Pharmaceuticals. Endo announced Sept. 28 that it entered into a definitive agreement to acquire Qualitest Pharmaceuticals, a leading, privately held generics company in the U.S., for approximately $1.2 billion in cash.
RegeneRx Biopharmaceuticals, Inc. announced today that the Company has been notified that two cardiac-related patents will be allowed in Australia and Mexico.
Cancer Genetics, Inc., a leader in oncology-focused personalized medicine, has launched a proprietary urogenital cancer array, UroGenRA, intended for kidney cancer diagnosis and subtyping in its own laboratory.
NYU Langone Medical Center has been awarded more than $30 million in research grants from the National Institute of Health (NIH) for 86 research projects being conducted at NYU School of Medicine across a broad range of basic science and clinical departments.
› Verified 5 days ago
News Archive
Endo Pharmaceuticals (Nasdaq: ENDP) announced today the completion of its acquisition of Qualitest Pharmaceuticals. Endo announced Sept. 28 that it entered into a definitive agreement to acquire Qualitest Pharmaceuticals, a leading, privately held generics company in the U.S., for approximately $1.2 billion in cash.
RegeneRx Biopharmaceuticals, Inc. announced today that the Company has been notified that two cardiac-related patents will be allowed in Australia and Mexico.
Cancer Genetics, Inc., a leader in oncology-focused personalized medicine, has launched a proprietary urogenital cancer array, UroGenRA, intended for kidney cancer diagnosis and subtyping in its own laboratory.
NYU Langone Medical Center has been awarded more than $30 million in research grants from the National Institute of Health (NIH) for 86 research projects being conducted at NYU School of Medicine across a broad range of basic science and clinical departments.
› Verified 5 days ago
Checotah Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1002 W Gentry Ave, Checotah, Oklahoma 74426 Phone: (918) 473-3838 | |
Walmart Pharmacy 10-0340 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 131 Paul Carr Dr, Checotah, Oklahoma 74426 Phone: (918) 473-5404 |